Exane Derivatives’s iShares MSCI Emerging Markets Asia ETF EEMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$185K Hold
2,720
0.11% 178
2022
Q1
$201K Buy
2,720
+432
+19% +$33.7K 0.06% 332
2021
Q4
$188K Buy
2,288
+84
+4% +$7.1K 0.05% 347
2021
Q3
$186K Hold
2,204
0.04% 410
2021
Q2
$199K Hold
2,204
0.05% 390
2021
Q1
$200K Buy
2,204
+228
+12% +$21.3K 0.06% 297
2020
Q4
$173K Buy
+1,976
New +$161K 0.05% 329

Other funds holding EEMA

Exane Derivatives's EEMA Position: Q2 2022 in Review

Exane Derivatives held its iShares MSCI Emerging Markets Asia ETF (EEMA) position steady in Q2 2022 at 2,720 shares worth $185K. The position accounts for 0.11% of the portfolio, ranked #178.

Exane Derivatives first reported a position in EEMA in Q4 2020 and has held it in 7 quarters since. The position peaked at $201K in Q1 2022. 93 funds tracked by Wall St. Rank hold EEMA as of Q2 2022.

  • Exane Derivatives held 2,720 shares of iShares MSCI Emerging Markets Asia ETF worth $185K as of Q2 2022.
  • Exane Derivatives left its iShares MSCI Emerging Markets Asia ETF share count unchanged in Q2 2022.
  • iShares MSCI Emerging Markets Asia ETF made up 0.11% of Exane Derivatives's portfolio in Q2 2022, its #178 holding.
  • Exane Derivatives first reported a position in iShares MSCI Emerging Markets Asia ETF in Q4 2020 and has held it in 7 quarters since.
  • Exane Derivatives's iShares MSCI Emerging Markets Asia ETF position peaked at $201K in Q1 2022.
  • 93 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets Asia ETF as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.